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background: Octogenarians represent ~35% of hospitalized older heart failure (HF) patients but they have been systematically excluded from 
most RCTs of ACE inhibitors or ARBs (ACEI-ARB). In the current analysis, we examined the association of their use with outcomes in octogenarians, 
especially on 30-day all-cause readmission, a target for reduction in the new Affordable Care Act.
Methods: Of the 3067 Medicare beneficiaries with decompensated HF and EF<45%,discharged alive from 106 U.S. hospitals (1998-2001), 1021 
were octogenarians, of which 966 had no contraindications and 642 (67%) received pre-discharge prescriptions for ACEI-ARB. Using propensity 
scores for ACEI-ARB use, a matched cohort of 245 pairs of patients was assembled and balanced on 32 baseline characteristics.
results: All-cause 30-day readmission occurred in 16% and 24% of matched patientsreceiving and not receiving ACEI-ARBs, resp. (HR, 0.65; 95% 
CI, 0.43-0.96; p=0.033;Figure). Similar association was observed for HF readmission (7% vs. 13% for no ACEI-ARB; HR, 0.47; 95 CI,0.26-0.86; 
p=0.015), but not with 30-day all-cause mortality (7% vs. 9%; HR; 95% CI, 0.43-1.50). HRs (95% CIs) for all-cause readmission, HF readmission and 
all-cause mortality at 6 month post-discharge were 0.63 (0.49-0.81),0.57 (0.40-0.81), and 0.78 (0.57-1.08),resp.
conclusions: Among hospitalized octogenarians with HFrEF, ACEI-ARB use was associated with lower 30-day and 6-month all-cause and HF 
readmissions, but not with all-cause mortality.
